871709-84-1 Usage
General Description
3-Amino-1H-indazole-5-carboxylic acid is a chemical compound with the molecular formula C8H6N4O2. It belongs to the class of indazole derivatives, which are known for their diverse range of biological activities. 3-aMino-1H-indazole-5-carboxylic acid contains an indazole ring with an amino group and a carboxylic acid functional group attached at the 3 and 5 positions, respectively. It may have potential applications in medicinal chemistry and pharmaceutical research due to its structural features and potential activity in biological systems. Further studies and research are needed to fully understand the potential uses and effects of 3-Amino-1H-indazole-5-carboxylic acid.
Check Digit Verification of cas no
The CAS Registry Mumber 871709-84-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,7,0 and 9 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 871709-84:
(8*8)+(7*7)+(6*1)+(5*7)+(4*0)+(3*9)+(2*8)+(1*4)=201
201 % 10 = 1
So 871709-84-1 is a valid CAS Registry Number.
871709-84-1Relevant articles and documents
Novel indazole derivatives, and use thereof
-
, (2019/08/12)
The present invention refers to novel indazole derivatives, or pharmaceutically acceptable salts; and including DYRK1A DYRK1B active ingredient (Dual non-specificity tyrosine phosphorylation in a non-regulated kinase 1a) or a pharmaceutical composition for preventing or treating related disorders are disclosed. (by machine translation)
INDAZOLES
-
Page/Page column 33, (2016/03/13)
The invention provides novel substituted indazole compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
3-AMINOINDAZOLES
-
Page/Page column 50-51, (2008/06/13)
Novel 3-aminoindazoles of formula (I) are SGK-inhibitors and can be used for treating SGK-related diseases and illnesses such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, and generally any type of fibroses and inflammatory processes.
